Commonwealth Equity Services »

Oncolytics Biotech shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $53k 61k 0.87
2024-06-30 $62k 63k 0.98
2024-03-31 $67k 63k 1.07
2023-12-31 $75k 56k 1.35

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Value Etf (VTV)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Commonwealth Equity Services

Top funds holding Oncolytics Biotech

Seeds Investor
International Assets Investment Management
Morgan Stanley
Goldman Sachs Group
Citadel Advisors
Royal Bank of Canada
Commonwealth Equity Services
CIBC World Markets
Geode Capital Management
Long Focus Capital Management
Virtu Financial
SeaCrest Wealth Management
Brave Asset Management
Newman Dignan & Sheerar
National Bank Of Canada /fi/

View all funds holding Oncolytics Biotech